Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
Weihuan Lin , Weijie Zhan , HaiYu Zhou
Background: Histopathological classification of operable early-stage lung adenocarcinoma may influence the intraoperative surgical decision and postoperative management for patients. However, it is difficult to comprehensively evaluate the grade of risk of operable lung adenocarcinoma based on preoperative CT imaging alone. Therefore, we aimed to establish a pathological grading model for patients with pulmonary nodules through preoperative CT imaging. Methods: This was a diagnostic, retrospective, multi-centric study conducted in two independent centers from January 1, 2019, to June 1, 2021. After inclusion and exclusion criteria, a total of 396 patients were included from two centers and were diagnosed as stage IA lung invasive adenocarcinoma (IAC). Patients (n=308) from the Guangdong Provincial People's Hospital with solitary pulmonary nodules were randomly divided into the training cohort (n=222) and the internal validation cohort (n=86). Patients from the Jiangxi Cancer Hospital comprised the external cohort (n=88). Their clinical characteristics and preoperative CT images were collected at the same high-quality standard. Extracted radiomic features from tumor and peritumor areas were selected via the least absolute shrinkage and selection operator (LASSO) algorithm for a radiomics model (RM) construction. Logistic Regression analysis was conducted to develop a novel multi-parameter model (MPM) that integrated clinical characteristics and radiomic features. The area under the curve (AUC) of the receiver operator characteristic curve (ROC) was calculated to compare the prediction performance of models. Results: The MPM composed of clinical characteristics and radiomic features performed better than RM. It achieved good predictive value for high-risk IAC. The AUC of MPM in the training cohort was 0.87 (95%CI, 0.81-0.92), which achieved better identification performance than the RM (See Table). Similarly, model comparisons were conducted in the two validation cohorts in which the MPM gained high AUC values of 0.78 (95%CI, 0.68-0.88) and 0.83 (95%CI, 0.74-0.91), respectively. In addition, the sensitivity of MPM was higher than 80.0% in the three cohorts. Conclusions: The MPM may be a practical and reliable tool for predicting the pathological risk of patients with solitary pulmonary nodules.
Cohort | Model | Sensitivity | Specificity | Accuracy | AUC (95%CI) |
---|---|---|---|---|---|
Training Internal validation External validation | RM | 0.80 | 0.76 | 0.77 | 0.82 (0.75-0.89) |
MPM | 0.86 | 0.73 | 0.76 | 0.87 (0.81-0.92) | |
RM | 0.92 | 0.53 | 0.64 | 0.75 (0.65-0.86) | |
MPM | 0.88 | 0.61 | 0.69 | 0.78 (0.68-0.88) | |
RM | 0.88 | 0.71 | 0.80 | 0.81 (0.71-0.90) | |
MPM | 0.81 | 0.69 | 0.75 | 0.83 (0.74-0.91) |
AUC, Area under the curve; CI, Confidence interval; RM, Radiomics model; MPM, Multi-parameter model
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2023 ASCO Annual Meeting
First Author: Yan Liu
2024 ASCO Annual Meeting
First Author: Chiharu Sako
2023 ASCO Annual Meeting
First Author: ChunYu Lin
2023 ASCO Annual Meeting
First Author: Wenhua Liang